Skip to content
Search

Latest Stories

‘Duty of Candour is not an add-on, it’s a fundamental part of pharmacy profession’

The General Pharmaceutical Council (GPhC) has developed two new resources- Keeping patients safe being open and honest and Pharmacy team toolkit – learning from incidents, to help pharmacists and pharmacy technicians fulfil the duty of candour – the professional responsibility to be open and honest with patients if/when something goes wrong.

The new resources bring together relevant existing policy, standards, and previous statements on the professional obligations of pharmacists and pharmacy technicians, with respect to candour.


It also emphasises that the duty of candour is not an add on – it’s a fundamental part of pharmacy professional practice.

The responsibility to be open and honest applies even in difficult or challenging times and it’s essential that professionals do the right thing for patients, their families and carers. Saying sorry meaningfully when things go wrong is vital for everyone involved.

Given the link with issues around liability and indemnity, the National Pharmacy Association and the Pharmacists’ Defence Association – as leading providers of professional indemnity - have also contributed to the new resources and highlighted the importance of openness and transparency in this context.

The additional toolkit for pharmacy teams includes real case studies and examples of notable practice about how pharmacy teams have learned from incidents, to improve patient safety outcomes and minimise the risk of these happening again.

All pharmacy teams are urged to use the new toolkit to prompt learning and reflection during pharmacy team meetings or other discussions. Whilst the toolkit examples are drawn from the GPhC’s inspections of community pharmacies, the professional duty to be candid applies in all sectors of pharmacy practice.

Roundtable on Duty of Candour

Chair of the GPhC, Gisela Abbam, hosted a roundtable meeting on the duty of candour on Monday (June 13), attended by the Chief Pharmaceutical Officers and organisations representing pharmacy professionals, employers and students, patients and the public and other regulators.

Gisela Abbam said: “All healthcare professionals have a duty of candour – this is a professional responsibility to be open and honest with patients when something goes wrong with their treatment or care which causes, or has the potential to cause, harm or distress.

“We know that pharmacy professionals are working in multi-disciplinary teams and taking on new clinical roles, and it’s important that they demonstrate the duty of candour in an increasing variety of complex situations.

“At our roundtable, we sought feedback on the new resources. We also discussed further actions that we can all take to make sure everyone working in pharmacy understands their responsibilities to be open and honest when things go wrong, and to improve patient safety.”

Chief executive of the GPhC, Duncan Rudkin, said: “Pharmacists and pharmacy technicians, across different settings, work hard to provide person-centred, safe and effective care to patients. But sometimes things go wrong. The way that professionals respond to these situations is key to supporting the people affected and improving patient safety for the future.

“Our new resources highlight the importance of saying sorry. Apologising to a patient does not mean that a professional is admitting legal liability for what has happened. It’s an acknowledgement that something could have gone better, and gives an opportunity for learning to improve patient safety outcomes and minimise the risk of the same thing happening again.”

Chief pharmaceutical officer for England, David Webb, said: “The duty of candour is an essential part of being a pharmacy professional in the NHS because it is fundamentally important to patients, families, carers and everyone who is involved.

“My experience is that when we take this approach, it is welcomed and engenders further trust and confidence in our professions.

“Finally, it is the way forward in terms of learning from errors and improving our systems so we continuously develop and improve.”

Chair of the Pharmacists’ Defence Association, Mark Koziol, said: “At the PDA we support the duty of candour and this new initiative by the GPhC.

“Taking a frank and honest approach is crucial, even if it means saying sorry and admitting an error has occurred.”

Head of advice and support services for the National Pharmacy Association, Jasmine Shah, said: “We are striving to move away from a blame culture towards a learning culture. It is important to acknowledge when something goes wrong and to help the patient understand what happened. What we aim for is a resolution that is supportive both of the patients and professionals involved.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less